Abstract
Nowadays, high morbidity and mortality of cardiovascular diseases (CVDs) and high comorbidity rate of neuropsychiatric disorders contribute to global burden of health and economics. Consequently, a discipline concerning abnormal connections between the brain and the heart and the resulting disease states, known as psychocardiology, has garnered interest among researchers. However, identifying a common pathway that physicians can modulate remains a challenge. Gut microbiota, a constituent part of the human intestinal ecosystem, is likely involved in mutual mechanism CVDs and neuropsychiatric disorder share, which could be a potential target of interventions in psychocardiology. This review aimed to discuss complex interactions from the perspectives of microbial and intestinal dysfunction, behavioral factors, and pathophysiological changes and to present possible approaches to regulating gut microbiota, both of which are future directions in psychocardiology.
Similar content being viewed by others
References
AbuRuz ME (2018) Anxiety and depression predicted quality of life among patients with heart failure. J Multidiscip Healthc 11:367–373
Adak A, Khan MR (2019) An insight into gut microbiota and its functionalities. Cell Mol Life Sci 76:473–493
Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23:716–724
Ahmad Kendong SM, Raja Ali RA, Nawawi KNM, Ahmad HF, Mokhtar NM (2021) Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer. Front Cell Infect Microbiol 11:744606
Al-Kaisey AM, Figgett W, Hawson J, Mackay F, Joseph SA et al (2023) Gut microbiota and atrial fibrillation: pathogenesis, mechanisms and therapies. Arrhythm Electrophysiol Rev 12:e14
Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43:1731–1737
Anderson KM, Ferranti EP, Alagha EC, Mykityshyn E, French CE et al (2022) The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure. Heart Fail Rev 27:2223–2249
Auteri M, Zizzo MG, Serio R (2015) GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation. Pharmacol Res 93:11–21
Baranyi A, Enko D, von Lewinski D, Rothenhäusler HB, Amouzadeh-Ghadikolai O et al (2021) Assessment of trimethylamine N-oxide (TMAO) as a potential biomarker of severe stress in patients vulnerable to posttraumatic stress disorder (PTSD) after acute myocardial infarction. Eur J Psychotraumatol 12:1920201
Barbaresko J, Rienks J, Nöthlings U (2018) Lifestyle indices and cardiovascular disease risk: a meta-analysis. Am J Prev Med 55:555–564
Bayer AL, Alcaide P (2021) MyD88: at the heart of inflammatory signaling and cardiovascular disease. J Mol Cell Cardiol 161:75–85
Beam A, Clinger E, Hao L (2021) Effect of diet and dietary components on the composition of the gut microbiota. Nutrients 13:2795
Bellono NW, Bayrer JR, Leitch DB, Castro J, Zhang C et al (2017) Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170:185-198.e16
Bhatt S, Nagappa AN, Patil CR (2020) Role of oxidative stress in depression. Drug Discov Today 25:1270–1276
Blandino P, Barnum CJ, Deak T (2006) The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1β responses to stress. J Neuroimmunol 173:87–95
Boncler M, Wu Y, Watala C (2019) The multiple faces of c-reactive protein-physiological and pathophysiological implications in cardiovascular disease. Molecules 24:2062
Borst K, Dumas AA, Prinz M (2021) Microglia: immune and non-immune functions. Immunity 54:2194–2208
Bu J, Huang S, Wang J, Xia T, Liu H et al (2021) The GABA(A) receptor influences pressure overload-induced heart failure by modulating macrophages in mice. Front Immunol 12:670153
Bunz M, Kindermann I, Karbach J, Wedegartner S, Bohm M et al (2015) Psychocardiology: how heart and psyche interact. Dtsch Med Wochenschr 140:117–124
Burford NG, Webster NA, Cruz-Topete D (2017) Hypothalamic-pituitary-adrenal axis modulation of glucocorticoids in the cardiovascular system. Int J Mol Sci 18:2150
Burger PM, Koudstaal S, Mosterd A, Fiolet ATL, Teraa M et al (2023) C-reactive protein and risk of incident heart failure in patients with cardiovascular disease. J Am Coll Cardiol 82:414–426
Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K et al (2017) Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry 82:472–487
Cai T, Zheng SP, Shi X, Yuan LZ, Hu H et al (2022) Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression. Front Cell Infect Microbiol 12:900652
Campaniello D, Corbo MR, Sinigaglia M, Speranza B, Racioppo A et al (2022) How diet and physical activity modulate gut microbiota: evidence, and perspectives. Nutrients 14:2456
Chareonrungrueangchai K, Wongkawinwoot K, Anothaisintawee T, Reutrakul S (2020) Dietary factors and risks of cardiovascular diseases: an umbrella review. Nutrients 12:1088
Chen L, He FJ, Dong Y, Huang Y, Wang C et al (2020) Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives: a randomized, double-blind, placebo-controlled trial. Hypertension 76:73–79
Chen Y, Zhou J, Wang L (2021) Role and mechanism of gut microbiota in human disease. Front Cell Infect Microbiol 11:625913
Chen SY, Wang TY, Zhao C, Wang HJ (2022) Oxidative stress bridges the gut microbiota and the occurrence of frailty syndrome. World J Gastroenterol 28:5547–5556
Christ T, Rozmaritsa N, Engel A, Berk E, Knaut M et al (2014) Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proc Natl Acad Sci U S A 111:11193–11198
Cohen BE, Edmondson D, Kronish IM (2015) State of the art review: depression, stress, anxiety, and cardiovascular disease. Am J Hypertens 28:1295–1302
Cole JE, Georgiou E, Monaco C (2010) The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm 2010:393946
DeMorrow S (2018) Role of the hypothalamic-pituitary-adrenal axis in health and disease. Int J Mol Sci 19:986
Deng F-L, Pan J-X, Zheng P, Xia J-J, Yin B-M et al (2019) Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques. Neuropsychiatr Dis Treat 15:1077–1088
Dicks LMT (2022) Gut Bacteria and Neurotransmitters. Microorganisms 10:1838
Dinan K, Dinan T (2022) Antibiotics and mental health: the good, the bad and the ugly. J Intern Med 292:858–869
Dixon A, Robertson K, Yung A, Que M, Randall H et al (2020) Efficacy of probiotics in patients of cardiovascular disease risk: a systematic review and meta-analysis. Curr Hypertens Rep 22:74
Douglass AM, Resch JM, Madara JC, Kucukdereli H, Yizhar O et al (2023) Neural basis for fasting activation of the hypothalamic-pituitary-adrenal axis. Nature 620:154–162
Drapala A, Szudzik M, Chabowski D, Mogilnicka I, Jaworska K et al (2020) Heart failure disturbs gut-blood barrier and increases plasma trimethylamine, a toxic bacterial metabolite. Int J Mol Sci 21:6161
Duan N, Zhang Y, Tan S, Sun J, Ye M et al (2022) Therapeutic targeting of STING-TBK1-IRF3 signalling ameliorates chronic stress induced depression-like behaviours by modulating neuroinflammation and microglia phagocytosis. Neurobiol Dis 169:105739
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G et al (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464:1357–1361
Dunn AJ, Berridge CW (1990) Is corticotropin-releasing factor a mediator of stress responses? Ann N Y Acad Sci 579:183–191
Dwyer JB, Aftab A, Radhakrishnan R, Widge A, Rodriguez CI et al (2020) Hormonal treatments for major depressive disorder: state of the art. Am J Psychiatry 177:686–705
Elagizi A, Kachur S, Carbone S, Lavie CJ, Blair SN (2020) A review of obesity, physical activity, and cardiovascular disease. Curr Obes Rep 9:571–581
Esteve E, Castro A, López-Bermejo A, Vendrell J, Ricart W et al (2007) Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity. Diabetes Care 30:939–945
Eussen SJ, Ueland PM, Vollset SE, Nygård O, Midttun Ø et al (2015) Kynurenines as predictors of acute coronary events in the Hordaland Health Study. Int J Cardiol 189:18–24
Fan Y, Shen BJ, Tay HY (2021) Depression, anxiety, perceived stress, and their changes predicted medical adherence over 9 months among patients with coronary heart disease. Br J Health Psychol 26:748–766
Fan J, Zhou Y, Meng R, Tang J, Zhu J et al (2023) Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study. BMC Med 21:163
Farhadi A, Banan A, Fields J, Keshavarzian A (2003) Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 18:479–497
Fedoce ADG, Ferreira F, Bota RG, Bonet-Costa V, Sun PY et al (2018) The role of oxidative stress in anxiety disorder: cause or consequence? Free Radic Res 52:737–750
Fluharty M, Taylor AE, Grabski M, Munafò MR (2017) The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res 19:3–13
Fulton S, Décarie-Spain L, Fioramonti X, Guiard B, Nakajima S (2022) The menace of obesity to depression and anxiety prevalence. Trends Endocrinol Metab 33:18–35
Galla S, Chakraborty S, Cheng X, Yeo J, Mell B et al (2018) Disparate effects of antibiotics on hypertension. Physiol Genomics 50:837–845
Ganesh BP, Nelson JW, Eskew JR, Ganesan A, Ajami NJ et al (2018) Prebiotics, probiotics, and acetate supplementation prevent hypertension in a model of obstructive sleep apnea. Hypertension 72:1141–1150
Geng ZH, Zhu Y, Li QL, Zhao C, Zhou PH (2022) Enteric nervous system: the bridge between the gut microbiota and neurological disorders. Front Aging Neurosci 14:810483
Goldberger JJ, Arora R, Buckley U, Shivkumar K (2019) Autonomic nervous system dysfunction: JACC Focus Seminar. J Am Coll Cardiol 73:1189–1206
Goswami SK, Ranjan P, Dutta RK, Verma SK (2021) Management of inflammation in cardiovascular diseases. Pharmacol Res 173:105912
Gragnoli C (2014) Proteasome modulator 9 gene SNPs, responsible for anti-depressant response, are in linkage with generalized anxiety disorder. J Cell Physiol 229:1157–1159
Guo M, Fan X, Tuerhongjiang G, Wang C, Wu H et al (2021) Targeted metabolomic analysis of plasma fatty acids in acute myocardial infarction in young adults. Nutr Metab Cardiovasc Dis 31:3131–3141
Gupta A, Khanna S (2017) Fecal Microbiota Transplantation. Jama 318:102
Hakhamaneshi MS, Abdolahi A, Vahabzadeh Z, Abdi M, Andalibi P (2021) Toll-Like receptor 4: a macrophage cell surface receptor is activated by trimethylamine-N-oxide. Cell J 23:516–522
Hassell JE Jr, Nguyen KT, Gates CA, Lowry CA (2019) The impact of stressor exposure and glucocorticoids on anxiety and fear. Curr Top Behav Neurosci 43:271–321
Hayakawa K, Kimura M, Kamata K (2002) Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol 438:107–113
He M, Tan CP, Xu YJ, Liu Y (2020) Gut microbiota-derived trimethylamine-N-oxide: a bridge between dietary fatty acid and cardiovascular disease? Food Res Int 138:109812
Herrmann-Lingen C (2019) Psychocardiology - current guidelines and clinical reality (reprinted). Psychother Psychosom Med Psychol 69:237–252
Hoving LR, de Vries MR, de Jong RCM, Katiraei S, Pronk A et al (2018) The prebiotic inulin aggravates accelerated atherosclerosis in hypercholesterolemic APOE*3-Leiden mice. Nutrients 10
Illiano P, Brambilla R, Parolini C (2020) The mutual interplay of gut microbiota, diet and human disease. Febs j 287:833–855
Jahnel T, Ferguson SG, Shiffman S, Schüz B (2019) Daily stress as link between disadvantage and smoking: an ecological momentary assessment study. BMC Public Health 19:1284
Jefferson JW (1985) Psychocardiology: meeting place of heart and mind. Psychosomatics 26:841–842
Jerala R (2007) Structural biology of the LPS recognition. Int J Med Microbiol 297:353–363
Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW (2019) Screening and management of depression in patients with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol 73:1827–1845
Johnson JD, Barnard DF, Kulp AC, Mehta DM (2019) Neuroendocrine regulation of brain cytokines after psychological stress. J Endocr Soc 3:1302–1320
Joseph P, Leong D, McKee M, Anand SS, Schwalm JD et al (2017) Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res 121:677–694
Junaković A, Skočić Hanžek M, Adamec I, Krbot Skorić M, Habek M (2023) A complex interplay between autonomic symptoms and symptoms of depression, anxiety, and stress. Neurol Sci 44:3169–3179
Kalesnikava VA, Clarke PJ, Mukherjee B, Sen S, Mezuk B (2022) Psychosocial stress and hypothalamic-pituitary-adrenal axis stress reactivity: variations by race and socioeconomic status among adults at risk of diabetes. Psychosom Med 84:813–821
Kalueff AV, Nutt DJ (2007) Role of GABA in anxiety and depression. Depress Anxiety 24:495–517
Katsimichas T, Theofilis P, Tsioufis K, Tousoulis D (2023) Gut microbiota and coronary artery disease: current therapeutic perspectives. Metabolites 13:256
Kim E, Zhao Z, Rzasa JR, Glassman M, Bentley WE et al (2021) Association of acute psychosocial stress with oxidative stress: evidence from serum analysis. Redox Biol 47:102138
Kim ES, Yoon BH, Lee SM, Choi M, Kim EH et al (2022) Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency. Exp Mol Med 54:103–114
Kirschner SK, Deutz NEP, Rijnaarts I, Smit TJ, Larsen DJ et al (2022) Impaired intestinal function is associated with lower muscle and cognitive health and well-being in patients with congestive heart failure. JPEN J Parenter Enteral Nutr 46:660–670
Konopelski P, Mogilnicka I (2022) Biological effects of indole-3-propionic acid, a gut microbiota-derived metabolite, and its precursor tryptophan in mammals’ health and disease. Int J Mol Sci 23:1222
Kozhevnikova MV, Krivova AV, Korobkova EO, Ageev AA, Shestakova KM et al (2022) Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease. Kardiologiia 62:40–48
Kuller LH, Tracy RP, Shaten J, Meilahn EN (1996) Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 144:537–547
Lam V, Su J, Koprowski S, Hsu A, Tweddell JS et al (2012) Intestinal microbiota determine severity of myocardial infarction in rats. Faseb J 26:1727–1735
Lee Y, Brietzke E, Cao B, Chen Y, Linnaranta O et al (2020) Development and implementation of guidelines for the management of depression: a systematic review. Bull World Health Organ 98:683–697h
Lewis CV, Taylor WR (2020) Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol Heart Circ Physiol 319:H1227-h1233
Li M, Li C, Yu H, Cai X, Shen X et al (2017) Lentivirus-mediated interleukin-1β (IL-1β) knock-down in the hippocampus alleviates lipopolysaccharide (LPS)-induced memory deficits and anxiety- and depression-like behaviors in mice. J Neuroinflammation 14:190
Li N, Wang Q, Wang Y, Sun A, Lin Y et al (2019) Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis. Stress 22:592–602
Liu RT, Walsh RFL, Sheehan AE (2019) Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev 102:13–23
Liu BN, Liu XT, Liang ZH, Wang JH (2021) Gut microbiota in obesity. World J Gastroenterol 27:3837–3850
Liu W, Zhang X, Wu Z, Huang K, Yang C et al (2022) Brain-heart communication in health and diseases. Brain Res Bull 183:27–37
Liu L, Wang H, Chen X, Zhang Y, Zhang H et al (2023) Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine 90:104527
Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42:145–151
Lund A, Nordrehaug JE, Slettom G, Solvang SH, Pedersen EK et al (2020) Plasma kynurenines and prognosis in patients with heart failure. PLoS ONE 15:e0227365
MacLeod C, Hadoke PWF, Nixon M (2021) Glucocorticoids: fuelling the fire of atherosclerosis or therapeutic extinguishers? Int J Mol Sci 22:7622
Meddings JB, Swain MG (2000) Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 119:1019–1028
Meinitzer S, Baranyi A, Holasek S, Schnedl WJ, Zelzer S et al (2020) Sex-specific associations of trimethylamine-N-oxide and zonulin with signs of depression in carbohydrate malabsorbers and nonmalabsorbers. Dis Markers 2020:7897240
Meng C, Feng S, Hao Z, Dong C, Liu H (2022) Antibiotics exposure attenuates chronic unpredictable mild stress-induced anxiety-like and depression-like behavior. Psychoneuroendocrinology 136:105620
Mensah GA, Roth GA, Fuster V (2019) The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 74:2529–2532
Michal M, Beutel M (2021) Mental disorders and cardiovascular disease: what should we be looking out for? Heart 107:1756–1761
Misiak B, Łoniewski I, Marlicz W, Frydecka D, Szulc A et al (2020) The HPA axis dysregulation in severe mental illness: can we shift the blame to gut microbiota? Prog Neuropsychopharmacol Biol Psychiatry 102:109951
Möhler H (2012) The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62:42–53
Moludi J, Khedmatgozar H, Nachvak SM, Abdollahzad H, Moradinazar M et al (2022) The effects of co-administration of probiotics and prebiotics on chronic inflammation, and depression symptoms in patients with coronary artery diseases: a randomized clinical trial. Nutr Neurosci 25:1659–1668
Navarro-Tapia E, Almeida-Toledano L, Sebastiani G, Serra-Delgado M, García-Algar Ó et al (2021) Effects of microbiota imbalance in anxiety and eating disorders: probiotics as novel therapeutic approaches. Int J Mol Sci 22:2351
Ng A, Tam WW, Zhang MW, Ho CS, Husain SF et al (2018) IL-1β, IL-6, TNF- α and CRP in elderly patients with depression or Alzheimer’s disease: systematic review and meta-analysis. Sci Rep 8:12050
Oakley RH, Cruz-Topete D, He B, Foley JF, Myers PH et al (2019) Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice. Sci Signal 12:eaau9685
O’Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin MT et al (2010) Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun 24:1074–1077
O’Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR et al (2022) Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol 546:111572
Pan Y, Chen XY, Zhang QY, Kong LD (2014) Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun 41:90–100
Peña JM, MacFadyen J, Glynn RJ, Ridker PM (2012) High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J 33:531–537
Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179:292–311
Qian B, Zhang K, Li Y, Sun K (2022) Update on gut microbiota in cardiovascular diseases. Front Cell Infect Microbiol 12:1059349
Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635–700
Rashid S, Qureshi AG, Noor TA, Yaseen K, Sheikh MAA et al (2023) Anxiety and depression in heart failure: an updated review. Curr Probl Cardiol 48:101987
Razquin C, Ruiz-Canela M, Toledo E, Hernández-Alonso P, Clish CB et al (2021) Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet. Am J Clin Nutr 114:1646–1654
Remme WJ (1998) The sympathetic nervous system and ischaemic heart disease. Eur Heart J 19(Suppl F):F62-71
Reynolds AN, Akerman A, Kumar S, Diep Pham HT, Coffey S et al (2022) Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses. BMC Med 20:139
Rotariu D, Babes EE, Tit DM, Moisi M, Bustea C et al (2022) Oxidative stress - complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders. Biomed Pharmacother 152:113238
Roth W, Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M (2021) Tryptophan metabolism and gut-brain homeostasis. Int J Mol Sci 22:2973
Rune I, Rolin B, Larsen C, Nielsen DS, Kanter JE et al (2016) Modulating the gut microbiota improves glucose tolerance, lipoprotein profile and atherosclerotic plaque development in ApoE-deficient mice. PLoS ONE 11:e0146439
Russell G, Lightman S (2019) The human stress response. Nat Rev Endocrinol 15:525–534
Sainte-Marie Y, Nguyen Dinh Cat A, Perrier R, Mangin L, Soukaseum C et al (2007) Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. Faseb J 21:3133–3141
Salmon P (2001) Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Clin Psychol Rev 21:33–61
Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S et al (2020) The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases. Nutrients 12:605
Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA (2019) Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol 16:605–616
Schweren LJS, Larsson H, Vinke PC, Li L, Kvalvik LG et al (2021) Diet quality, stress and common mental health problems: a cohort study of 121,008 adults. Clin Nutr 40:901–906
Scott-Solomon E, Boehm E, Kuruvilla R (2021) The sympathetic nervous system in development and disease. Nat Rev Neurosci 22:685–702
Selim AM, Sarswat N, Kelesidis I, Iqbal M, Chandra R et al (2017) Plasma serotonin in heart failure: possible marker and potential treatment target. Heart Lung Circ 26:442–449
Senoner T, Dichtl W (2019) Oxidative stress in cardiovascular diseases: still a therapeutic target? Nutrients 11:2090
Seravalle G, Mancia G, Grassi G (2014) Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease. High Blood Press Cardiovasc Prev 21:89–105
Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM et al (2003) C-reactive protein and the risk of developing hypertension. JAMA 290:2945–2951
Sethwala AM, Goh I, Amerena JV (2021) Combating inflammation in cardiovascular disease. Heart Lung Circ 30:197–206
Shandilya S, Kumar S, Kumar Jha N, Kumar Kesari K, Ruokolainen J (2022) Interplay of gut microbiota and oxidative stress: perspective on neurodegeneration and neuroprotection. J Adv Res 38:223–244
Sharkey KA, Mawe GM (2023) The enteric nervous system. Physiol Rev 103:1487–1564
Shen MJ, Choi EK, Tan AY, Lin SF, Fishbein MC et al (2011) Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol 9:30–39
Sies H (2015) Oxidative stress: a concept in redox biology and medicine. Redox Biol 4:180–183
Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG et al (2021) The gut microbiota in anxiety and depression - a systematic review. Clin Psychol Rev 83:101943
Singh V, Ahlawat S, Mohan H, Gill SS, Sharma KK (2022) Balancing reactive oxygen species generation by rebooting gut microbiota. J Appl Microbiol 132:4112–4129
Sorgdrager FJH, Doornbos B, Penninx B, de Jonge P, Kema IP (2017) The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls. J Affect Disord 222:32–39
Stetler C, Miller GE (2011) Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 73:114–126
Stevens BR, Goel R, Seungbum K, Richards EM, Holbert RC et al (2018) Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression. Gut 67:1555–1557
Stone LB, McCormack CC, Bylsma LM (2020) Cross system autonomic balance and regulation: associations with depression and anxiety symptoms. Psychophysiology 57:e13636
Sweeney RP, Lowary TL (2019) New insights into lipopolysaccharide assembly and export. Curr Opin Chem Biol 53:37–43
Sylvestre M, Di Carlo SE, Peduto L (2023) Stromal regulation of the intestinal barrier. Mucosal Immunol 16:221–231
Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241–248
Tang WHW, Li DY, Hazen SL (2019) Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol 16:137–154
Thomas MS, Fernandez ML (2021) Trimethylamine N-oxide (TMAO), diet and cardiovascular disease. Curr Atheroscler Rep 23:12
Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M et al (2022) Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther 236:108053
Tomiyama AJ (2019) Stress and obesity. Annu Rev Psychol 70:703–718
Tousoulis D, Guzik T, Padro T, Duncker DJ, De Luca G et al (2022) Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation. Cardiovasc Res 118:3171–3182
Triposkiadis F, Briasoulis A, Kitai T, Magouliotis D, Athanasiou T et al (2023) The sympathetic nervous system in heart failure revisited. Heart Fail Rev. https://doi.org/10.1007/s10741-023-10345-y
Trøseid M, Andersen G, Broch K, Hov JR (2020) The gut microbiome in coronary artery disease and heart failure: current knowledge and future directions. EBioMedicine 52:102649
Trzeciak P, Herbet M (2021) Role of the intestinal microbiome, intestinal barrier and psychobiotics in depression. Nutrients 13:927
Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A et al (2012) Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun 425:162–168
Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA (2022) The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol 80:2361–2371
Vakharia K, Hinson JP (2005) Lipopolysaccharide directly stimulates cortisol secretion by human adrenal cells by a cyclooxygenase-dependent mechanism. Endocrinology 146:1398–1402
van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C et al (2018) Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. J Physiol 596:4923–4944
van der Pol A, van Gilst WH, Voors AA, van der Meer P (2019) Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail 21:425–435
Verhaar BJH, Prodan A, Nieuwdorp M, Muller M (2020) Gut microbiota in hypertension and atherosclerosis: a review. Nutrients 12:2982
Vicentini FA, Keenan CM, Wallace LE, Woods C, Cavin JB et al (2021) Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome 9:210
Vikenes K, Farstad M, Nordrehaug JE (1999) Serotonin is associated with coronary artery disease and cardiac events. Circulation 100:483–489
Wang D, Wu J, Zhu P, Xie H, Lu L et al (2022) Tryptophan-rich diet ameliorates chronic unpredictable mild stress induced depression- and anxiety-like behavior in mice: the potential involvement of gut-brain axis. Food Res Int 157:111289
Wehrwein EA, Orer HS, Barman SM (2016) Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system. Compr Physiol 6:1239–1278
Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM et al (2019) How probiotics affect the microbiota. Front Cell Infect Microbiol 9:454
Witkowski M, Weeks TL, Hazen SL (2020) Gut microbiota and cardiovascular disease. Circ Res 127:553–570
Wu H, Chiou J (2021) Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients 13:2878
Wu Y, Zhu B, Chen Z, Duan J, Luo A et al (2021) New insights into the comorbidity of coronary heart disease and depression. Curr Probl Cardiol 46:100413
Xue C, Li G, Zheng Q, Gu X, Shi Q et al (2023) Tryptophan metabolism in health and disease. Cell Metab 35:1304–1326
Yan X, Jin J, Su X, Yin X, Gao J et al (2020) Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension. Circ Res 126:839–853
Zannad F (2019) Autonomic nervous system modulation in heart failure: do we need another trial? Circ Heart Fail 12:e006491
Zhang J, Zuo K, Fang C, Yin X, Liu X et al (2021) Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation. BMC Genomics 22:634
Zhang H, Lin Z, Chen J, Gan D, Zhou H et al (2022a) Association between dietary fiber intake and heart failure among adults: national health and nutrition examination survey 2009–2018. Front Cardiovasc Med 9:893436
Zhang Y, Zhang S, Li B, Luo Y, Gong Y et al (2022b) Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome. Cardiovasc Res 118:785–797
Zhou X, Li J, Guo J, Geng B, Ji W et al (2018) Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome 6:66
Zhu Q, Gao R, Zhang Y, Pan D, Zhu Y et al (2018) Dysbiosis signatures of gut microbiota in coronary artery disease. Physiol Genomics 50:893–903
Funding
This work was supported by grants from the National Natural Science Foundation of China (to LY, 82070405), the Leading Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project (to LY, No. 2022260), the Changzhou Key Medical Discipline (to LY, No. CZXK202202), and the Jiangsu Province’s 333 Research Project (to RZ, 2022, 3-4-109).
Author information
Authors and Affiliations
Contributions
LY and RZ conceived this work. YZ and KH drafted the manuscript. LY and JD conducted the review and revision. All the authors have approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, Y., Huang, K., Duan, J. et al. Gut microbiota connects the brain and the heart: potential mechanisms and clinical implications. Psychopharmacology 241, 637–651 (2024). https://doi.org/10.1007/s00213-024-06552-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-024-06552-6